Label: DOCUSATE SODIUM capsule, liquid filled
- NDC Code(s): 68210-0305-1, 68210-0305-3
- Packager: Spirit Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 13, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each gelcaps)
- Purpose
- Uses
- Do not use
- Ask a doctor before use if you
- Stop use abd ask a doctor if you
- If pregnant or breast-feeding
- Stop use and ask a doctor if you
- If pregnant or breast feeding
- Keep out of reach of children
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
- PRINCIPAL DISPLAY PANEL- Valumeds Stool Softener 100capgels Bottle Labels
-
INGREDIENTS AND APPEARANCE
DOCUSATE SODIUM
docusate sodium capsule, liquid filledProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68210-0305 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 100 mg Inactive Ingredients Ingredient Name Strength POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SHELLAC (UNII: 46N107B71O) WATER (UNII: 059QF0KO0R) GELATIN (UNII: 2G86QN327L) GLYCERIN (UNII: PDC6A3C0OX) SORBITOL (UNII: 506T60A25R) D&C RED NO. 33 (UNII: 9DBA0SBB0L) FD&C RED NO. 40 (UNII: WZB9127XOA) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color white, red Score no score Shape CAPSULE Size 12mm Flavor Imprint Code 413 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68210-0305-1 100 in 1 BOTTLE; Type 0: Not a Combination Product 05/18/2017 2 NDC:68210-0305-3 1 in 1 CARTON 04/11/2018 2 30 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 05/18/2017 Labeler - Spirit Pharmaceuticals LLC (179621011)